News Roundup: September 19 to September 23
Your weekly roundup of the latest news from Drug Topics®.
Nonopioid Pain Reliever Prescriptions on the Rise, as Opioid Prescriptions Decline
Study finds growth in three years after CDC guideline for primary care clinicians.
FDA, Medtronic Alert Users to Cybersecurity Risk with MiniMed 600 Systems
The risk could allow unauthorized users to change insulin levels.
Impaired Quality of Life, Disease Burden Felt by Patients with Moderate-to-Severe Atopic Dermatitis
A national study in Germany identified the baseline characteristics of patients with moderate-to-severe atopic dermatitis to understand how they are usually treated with Dupixent in the real world.
Housing, Food Insecurity Can Be Caused By Medical Debt
Hospitalization, disability, having private high-deductible, Medicare Advantage, or no coverage were risk factors associated with medical debt.
Open-Source Automated Insulin Delivery Systems May Lead to Glycemic Control Improvement in Type 1 Diabetes
Research indicates that using an open-source automated insulin delivery systems can lead to greater glycemic control.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
